
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Immunol. , 06 January 2025
Sec. Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1544371
This article is a correction to:
The causal relationship between serum metabolites and the risk of psoriasis: a Mendelian randomization and meta-analysis study
A Corrigendum on
The causal relationship between serum metabolites and the risk of psoriasis: a Mendelian randomization and meta-analysis study
By Yang Y, Zheng X, Lv H, Tang B, Zhong Y, Luo Q, Bi Y, Yang K, Zhong H, Chen H and Lu C (2024) Front. Immunol. 15:1343301. doi: 10.3389/fimmu.2024.1343301
In the published article, there was an error in Figure 4 as published. The duplicate Figure 4B was mistakenly uploaded to the position of Figure 4C. The corrected Figure 4 and its caption appear below.
Figure 4. (A) displays the heterogeneity and pleiotropy analysis results of 24 metabolites that have been successfully validated. (B) displays the enrichment pathways of metabolites in KEGG and (C) displays the enrichment pathways of metabolites in SMPDE database.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: psoriasis, Mendelian randomization, metabolites, causal effect, implication
Citation: Yang Y, Zheng X, Lv H, Tang B, Zhong Y, Luo Q, Bi Y, Yang K, Zhong H, Chen H and Lu C (2025) Corrigendum: The causal relationship between serum metabolites and the risk of psoriasis: a Mendelian randomization and meta-analysis study. Front. Immunol. 15:1544371. doi: 10.3389/fimmu.2024.1544371
Received: 12 December 2024; Accepted: 16 December 2024;
Published: 06 January 2025.
Edited and Reviewed by:
Yejun Tan, University of Minnesota Health Twin Cities, United StatesCopyright © 2025 Yang, Zheng, Lv, Tang, Zhong, Luo, Bi, Yang, Zhong, Chen and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Haiming Chen, aGVtaW4wNjZAZ3p1Y20uZWR1LmNu; Chuanjian Lu, bGNqQGd6dWNtLmVkdS5jbg==
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.